Develops blood tests for prostate cancer diagnosis.
Jun 2026Revenue $646K/yrExpenses $17.0M/yr
No trend
Figures by year
When will Onconetix be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $646K and expenses $17.0M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $815K | $18.7M | −$17.9M |
| Dec 2024 | $2.52M | $59.0M | −$56.5M |
| Dec 2023 | $58.5K | $36.1M | −$36.0M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.